Author/Creator: Pratley, Richard E - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Pratley, Richard E

1. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Issue 10 (October 2021)

Authors:: Sattar, Naveed; Lee, Matthew M Y; Kristensen, Søren L; Branch, Kelley R H; Del Prato, Stefano; Khurmi, Nardev S; Lam, Carolyn S P; Lopes, Renato D; McMurray, John J V; Pratley, Richard E; Rosenstock, Julio; Gerstein, Hertzel C
Journal:: Lancet
Issue:: Volume 9:Issue 10(2021)
Page Start:: 653
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial. (January 2016)

Authors:: Wolk, Robert; Bertolet, Marnie; Brooks, Maria M; Pratley, Richard E; Sobel, Burton E; Frye, Robert L; Singh, Prachi; Calvin, Andrew D; Rutter, Martin K; Mooradian, Arshag D; Somers, Virend K
Journal:: European journal of preventive cardiology
Issue:: Volume 23:Number 1(2016)
Page Start:: 50
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial. (29th August 2020)

Authors:: Wolk, Robert; Bertolet, Marnie; Brooks, Maria M; Pratley, Richard E; Sobel, Burton E; Frye, Robert L; Singh, Prachi; Calvin, Andrew D; Rutter, Martin K; Mooradian, Arshag D; Somers, Virend K
Journal:: European journal of preventive cardiology
Issue:: Volume 23:Number 1(2016)
Page Start:: 50
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline. Issue 1 (18th January 2022)

Authors:: Pratley, Richard E; Jacob, Stephan; Baek, Seungjae; Trautmann, Michael E; Hompesch, Marcus; Han, OakPil; Stewart, John; Sorli, Christopher H; Shaunik, Alka; Yoon, Kun-Ho
Journal:: BMJ open diabetes research and care
Issue:: Volume 10:Issue 1(2022)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE. Issue 2 (24th November 2021)

Authors:: Klein, Klara R; Franek, Edward; Marso, Steven; Pieber, Thomas R; Pratley, Richard E; Gowda, Amoolya; Kvist, Kajsa; Buse, John B
Journal:: BMJ open diabetes research and care
Issue:: Volume 9:Issue 2(2021)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses. Issue 11 (16th November 2020)

Authors:: Pratley, Richard E; Aroda, Vanita R; Catarig, Andrei-Mircea; Lingvay, Ildiko; Lüdemann, Jörg; Yildirim, Emre; Viljoen, Adie
Journal:: BMJ open
Issue:: Volume 10:Issue 11(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses. Issue 11 (16th November 2020)

Authors:: Pratley, Richard E; Aroda, Vanita R; Catarig, Andrei-Mircea; Lingvay, Ildiko; Lüdemann, Jörg; Yildirim, Emre; Viljoen, Adie
Journal:: BMJ open
Issue:: Volume 10:Issue 11(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses. Issue 11 (16th November 2020)

Authors:: Pratley, Richard E; Aroda, Vanita R; Catarig, Andrei-Mircea; Lingvay, Ildiko; Lüdemann, Jörg; Yildirim, Emre; Viljoen, Adie
Journal:: BMJ open
Issue:: Volume 10:Issue 11(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses. Issue 11 (16th November 2020)

Authors:: Pratley, Richard E; Aroda, Vanita R; Catarig, Andrei-Mircea; Lingvay, Ildiko; Lüdemann, Jörg; Yildirim, Emre; Viljoen, Adie
Journal:: BMJ open
Issue:: Volume 10:Issue 11(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses. Issue 11 (16th November 2020)

Authors:: Pratley, Richard E; Aroda, Vanita R; Catarig, Andrei-Mircea; Lingvay, Ildiko; Lüdemann, Jörg; Yildirim, Emre; Viljoen, Adie
Journal:: BMJ open
Issue:: Volume 10:Issue 11(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗